Search

Your search keyword '"Hata, Kenichi"' showing total 139 results

Search Constraints

Start Over You searched for: Author "Hata, Kenichi" Remove constraint Author: "Hata, Kenichi"
139 results on '"Hata, Kenichi"'

Search Results

4. Radiographic Progression at Castration-Resistant Prostate Cancer Diagnosis: A Prognostic Indicator of Metastatic Hormone-Sensitive Prostate Cancer

5. Combination of docetaxel versus nonsteroidal antiandrogen with androgen deprivation therapy for high-volume metastatic hormone-sensitive prostate cancer: a propensity score-matched analysis

6. Comparative adverse event profiles of triplet therapy versus docetaxel-based therapy in patients with metastatic prostate cancer: a multicenter retrospective study

7. Comparison of efficacy and medical costs between upfront docetaxel and abiraterone treatments of metastatic hormone-sensitive prostate cancer patients in real-world practice: a multicenter retrospective study

8. Real-world outcomes and risk stratification in patients with metastatic castration-sensitive prostate cancer treated with upfront abiraterone acetate and docetaxel

9. Prognostic model for second progression‐free survival and overall survival in patients with high‐risk metastatic hormone‐sensitive prostate cancer treated with abiraterone acetate and androgen deprivation therapy.

10. Real-world survival outcomes of adding docetaxel or abiraterone in patients with high-volume metastatic castration-sensitive prostate cancer: historically controlled, propensity score matched comparison with androgen deprivation therapy

11. Contributors

12. Trends in pregnancy and birth after the Great East Japan earthquake and Fukushima Daiichi nuclear power plant accident in the Fukushima prefecture: A 7-year survey

13. Real-world evidence of triplet therapy efficacy in patients with metastatic castration-sensitive prostate cancer: a Japanese multicenter study.

14. Acquired Hemophilia A Diagnosed Based on Gross Hematuria: A Case Report and Literature Review.

15. MP11-12 DEVELOPMENT OF A RISK MODEL FOR TIME TO SECOND PROGRESSION IN PATIENTS WITH HIGH-RISK METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER TREATED WITH ABIRATERONE ACETATE AND ANDROGEN DEPRIVATION THERAPY

16. Docetaxel versus abiraterone for metastatic hormone‐sensitive prostate cancer with focus on efficacy of sequential therapy

17. Comparison of efficacy and medical costs between upfront docetaxel and abiraterone treatments of metastatic hormone-sensitive prostate cancer patients in real-world practice: a multicenter retrospective study

18. Effects of External Radiation Exposure on Perinatal Outcomes in Pregnant Women After the Fukushima Daiichi Nuclear Power Plant Accident: the Fukushima Health Management Survey

19. The Effects of the Great East Japan Earthquake on Perinatal Outcomes: Results of the Pregnancy and Birth Survey in the Fukushima Health Management Survey

21. Eight-year trends in the effect of the Great East Japan Earthquake on obstetrics outcomes using the Fukushima Health Management Survey

22. Does castration status affect docetaxel‐related adverse events? :Identification of risk factors for docetaxel‐related adverse events in metastatic prostate cancer

23. Effect of upfront intensive therapy on oncological outcomes in older patients with high tumor burden metastatic castration‐sensitive prostate cancer: A multicenter retrospective study

25. Combination of docetaxel versus nonsteroidal antiandrogen with androgen deprivation therapy for high-volume metastatic hormone-sensitive prostate cancer: a propensity score-matched analysis

26. PD35-11 THE IMPACT OF OLDER AGE ON THE ONCOLOGICAL OUTCOMES FOR HIGH-RISK METASTATIC HORMONE-SENSITIVE PROSTATE CANCER TREATED WITH UPFRONT INTENSIVE THERAPY

27. Low Body Weight as a Risk Factor for Apalutamide-related Cutaneous Adverse Events

28. Abiraterone acetate versus nonsteroidal antiandrogen with androgen deprivation therapy for high‐risk metastatic hormone‐sensitive prostate cancer

29. Prognostic model with alkaline phosphatase, lactate dehydrogenase and presence of Gleason pattern 5 for worse overall survival in low-risk metastatic hormone-sensitive prostate cancer

35. Abiraterone acetate versus nonsteroidal antiandrogen with androgen deprivation therapy for high‐risk metastatic hormone‐sensitive prostate cancer.

37. The association of PSA levels and survival outcomes in patients with chemotherapy-naïve, castration-resistant prostate cancer (CRPC) who were treated with androgen receptor signaling axis targeting agent (ARAT): A Japanese cohort study.

38. Docetaxel for Small Cell Carcinoma of the Prostate with a Metastatic Pelvic Tumor : A Case Report

41. Safety of fondaparinux for prevention of postoperative venous thromboembolism in urological malignancy: A prospective randomized clinical trial

46. PREGNANT AND BIRTH SURVEY AFTER THE GREAT EAST JAPAN EARTHQUAKE AND FUKUSHIMA DAIICHI NUCLEAR POWER PLANT ACCIDENT IN FUKUSHIMA PREFECTURE

47. RISK FACTORS FOR INTRAVESICAL RECURRENCE AFTER SURGICAL MANAGEMENT OF UROTHERIAL CARCINOMA OF THE UPPER URINARY TRACT

48. This title is unavailable for guests, please login to see more information.

Catalog

Books, media, physical & digital resources